BCMA CAR-T cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BCMA CAR-T cells, covering 2021-10-27 to 2022-08-05. Get the full timeline:
Most recent: Clinical Trial Update: Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma [Phase 1]